XLO · Xilio Therapeutics, Inc. · Earnings Call Transcripts & Audio
Market Cap
$51.64M
Shares
5.78M
Xilio Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Xilio Therapeutics, Inc. (XLO), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
Earnings call
FY25 · Q3
2025-11-13
Xilio Therapeutics, Inc. (XLO) Q3 2025 Earnings Call
Revenue
$19.07M
▲ 742.5% YoY Diluted EPS
$-1.54
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-11-07
Xilio Therapeutics, Inc. (XLO) Q3 2024 Earnings Call
Revenue
$2.26M
Diluted EPS
$-3.08
Rev · 2q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-28
Xilio Therapeutics, Inc. (XLO) Q4 2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q2
2023-08-14
Xilio Therapeutics, Inc. (XLO) Q2 2023 Earnings Call
Diluted EPS
$-9.80
Audio
Transcript
Slides
8-K10-Q
Showing 1–4 of 4 earnings calls
Key facts
CIK
1840233
CUSIP
98422T209
13F (30d)
13 filings
13 filers
Visit website
Investor relations